Company profile: Exela Pharma Sciences
1.1 - Company Overview
Company description
- Provider of sterile injectable pharmaceuticals for the healthcare sector, offering Sodium Bicarbonate Injection (electrolyte replenisher/systemic alkalizer), Caffeine Citrate Injection, ELCYS (cysteine hydrochloride injection), GLYRX-PF (synthetic anticholinergic), Nipride RTU (sodium nitroprusside), and Caffeine Citrate Oral Solution.
Products and services
- ELCYS (cysteine hydrochloride injection): Creates a clear, colorless, sterile solution for intravenous use, featuring a nonpyrogenic profile to support IV administration of cysteine hydrochloride in the healthcare sector
- Nipride RTU: Supplies a sterile, unpreserved, colorless to red-brown solution of sodium nitroprusside for intravenous use, enabling intravenous administration of sodium nitroprusside in the healthcare sector
- Sodium Bicarbonate Injection: Delivers a sterile, nonpyrogenic, hypertonic solution of sodium bicarbonate in water for injection, used as an electrolyte replenisher and systemic alkalizer in the healthcare sector
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Exela Pharma Sciences
Ascential Technologies
HQ: United States
Website
- Description: Provider of design, development, testing, manufacturing, and automation solutions for medical devices and life sciences; vehicle testing and automation (wheel alignment, emissions, driver assistance systems) via Burke Porter; and industrial sectors like HVAC and energy, offering test and measurement systems, balancing equipment, lifecycle services, and lab products such as dynamometers and NVH testers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ascential Technologies company profile →
Medical Science & Computing
HQ: United States
Website
- Description: Provider of advanced data analytics and AI to support health, human services, and public safety missions; enterprise digital modernization and system integration; and cloud adoption and infrastructure optimization to enhance performance, reduce costs, improve public health, strengthen research and IT capabilities, and optimize operational outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Science & Computing company profile →
Beghou Consulting
HQ: United States
Website
- Description: Provider of management consulting, data solutions, and advanced analytics for life sciences companies, serving the US and India. Services span commercial operations improvement, sales force design, segmentation and targeting, incentive compensation design and administration, forecasting, omnichannel orchestration, and data collection/integration with advanced analytics including machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beghou Consulting company profile →
CITrials
HQ: United States
Website
- Description: Provider of pharmaceutical medical research conducting clinical trials across Phase I-IV to evaluate safety, efficacy, dosing, and long-term effectiveness of investigational and approved drugs. Offers studies in mental health conditions, including depression, anxiety, bipolar disorder, and schizophrenia, and women's health, including reproductive health and other gender-specific conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CITrials company profile →
Argon Network
HQ: United Kingdom
Website
- Description: Provider of an international network of independent healthcare agencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Argon Network company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Exela Pharma Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Exela Pharma Sciences
2.2 - Growth funds investing in similar companies to Exela Pharma Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Exela Pharma Sciences
4.2 - Public trading comparable groups for Exela Pharma Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →